Baseline Characteristics of AMYPAD-DPMS Participants
Anxiety, cognitive decline, cognitive impairment, MCI, Depression
ALZHEIMER DISEASE
Abbreviations: AD, Alzheimer disease; HADS, Hospital Anxiety and Depression Scale; MCI, mild cognitive impairment; MMSE, Mini-Mental State Examination; SCD+, subjective cognitive decline plus clinical features increasing the likelihood of preclinical AD.The table illustrates the main sociodemographic and clinical features of the AMYPAD-DPMS participants included in the main outcome analysis (intention-to-treat analysis). At baseline, cognitive stages and etiological diagnoses were based on clinical and cognitive assessment and MRI or computed tomography.Ethnicity data were collected by members of the AMYPAD-DPMS study team at the local recruiting memory clinics, who chose among options on an electronic case report form. White ethnicity included those reported as British, Irish, White, and any other White background; the other groups were African, Asian or Asian British, Black or Black British, Caribbean, Chinese, Indian, multiracial (listed as “mixed”), Pakistani, White and Black African, White and Black Caribbean, any other Asian background, any other multiracial background, and not stated.Calculated as weight in kilograms divided by height in meters squared.Information on the managing physicians involved in the clinical assessment of the AMYPAD-DPMS participants is reported in the eResults in 